Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €1.15 EUR
Change Today -0.056 / -4.66%
Volume 0.0
NLZB On Other Exchanges
NLZB is not on other exchanges.
As of 1:24 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

neurometrix inc (NLZB) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/8/14 - €2.21
52 Week Low
04/27/15 - €1.14
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NEUROMETRIX INC (NLZB)

Related News

No related news articles were found.

neurometrix inc (NLZB) Related Businessweek News

No Related Businessweek News Found

neurometrix inc (NLZB) Details

NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease and spinal stenosis, and diabetes. The company develops wearable medical technology and point-of-care tests that help patients and physicians manage chronic pain, nerve diseases, and sleep disorders. Its marketed products include Quell, a wearable device for relief of chronic pain, such as nerve pain due to diabetes and lower back problems; the SENSUS pain therapy device, a prescription neurostimulation device based on transcutaneous electrical nerve stimulation for relief of chronic, intractable pain; DPNCheck, a test used to evaluate systemic neuropathies, such as diabetic peripheral neuropathy; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the assessment of carpal tunnel syndrome. The company distributes its products through its direct sales force and independent sales representatives to physicians, clinics, hospitals, managed care organizations, retail health businesses, and independent distributors consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons primarily in the United States, Europe, Asia, and the Middle East. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.

32 Employees
Last Reported Date: 02/25/15
Founded in 1996

neurometrix inc (NLZB) Top Compensated Officers

Founder, Chairman, Chief Executive Officer, P...
Total Annual Compensation: $414.2K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $300.4K
Senior Vice President and General Manager of ...
Total Annual Compensation: $150.1K
Compensation as of Fiscal Year 2014.

neurometrix inc (NLZB) Key Developments

NeuroMetrix Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2015

NeuroMetrix Inc. announced unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenues of $1,282,960 compared to $1,331,537 a year ago. Loss from operations was $3,258,619 compared to $1,740,235 a year ago. Net loss was $2,071,228 compared to $1,224,599 a year ago. Net loss per common share applicable to common stockholders, basic and diluted was $0.25 compared to $0.21 a year ago. Net cash usage during the quarter was approximately $2.8 million.

NeuroMetrix Inc. to Report Q1, 2015 Results on Apr 21, 2015

NeuroMetrix Inc. announced that they will report Q1, 2015 results at 9:00 AM, Eastern Standard Time on Apr 21, 2015

NeuroMetrix Inc., Q1 2015 Earnings Call, Apr 21, 2015

NeuroMetrix Inc., Q1 2015 Earnings Call, Apr 21, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NLZB:GR €1.15 EUR -0.056

NLZB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Natus Medical Inc $41.03 USD -1.12
View Industry Companies

Industry Analysis


Industry Average

Valuation NLZB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.9x
Price/Book 6.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUROMETRIX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at